Researchers Developed A Novel Class Of Synthetic Molecules That Target Prostate Cancer Cells

Researchers Developed A Novel Class Of Synthetic Molecules That Target Prostate Cancer Cells
A novel class of synthetic molecules with the targeting and effector functions of antibodies were synthesized to induce a highly targeted immune response against prostate cancer. The study entitled “Chemically Synthesized Molecules with the Targeting and Effector Functions of Antibodies” was published in the Journal of the American Chemical Society by Patrick J. McEnaney part

Knowledge is power when living with prostate cancer.

Get access to the web’s leading Prostate Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *